Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proflavine hemisulfate is a topical fluorescent contrast agent and small molecule vital dye used primarily in clinical research for the real-time detection of gastrointestinal neoplasia. It functions by intercalating into DNA, which selectively labels cell nuclei and allows for high-resolution fluorescence imaging of cellular architecture during endoscopic procedures. In studies led by Dr. Sharmila Anandasabapathy, a 0.01% w/v solution is applied topically to the esophageal or gastric mucosa to assist clinicians in distinguishing neoplastic tissue from non-neoplastic tissue in patients with Barrett's esophagus and gastroesophageal reflux disease (GERD). While historically utilized as an antibacterial agent in umbilical cord care, its modern application in gastroenterology leverages its peak absorption (445-455 nm) and emission (515 nm) properties for use with confocal microendoscopy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on proflavine hemisulfate.